Suppr超能文献

雌激素受体在雄性大鼠肝脏再生中的作用。

Role of the oestrogen receptor in liver regeneration in the male rat.

作者信息

Liddle C, Farrell G C

机构信息

Department of Gastroenterology and Hepatology, Westmead Hospital, University of Sydney, New South Wales, Australia.

出版信息

J Gastroenterol Hepatol. 1993 Nov-Dec;8(6):524-9. doi: 10.1111/j.1440-1746.1993.tb01646.x.

Abstract

Partial hepatectomy in male rats results in raised serum oestrogen levels, nuclear binding of oestrogen receptor (ER) and feminization of certain aspects of hepatic metabolism. It has been proposed that these changes may have an important role in liver regeneration. The present study was performed to ascertain the effects of the oestrogen agonist diethylstilbestrol (DES), 2 mg/kg, and the oestrogen antagonist tamoxifen (TAM), 2 mg/kg, on liver regeneration induced by partial hepatectomy in the male rat. Regenerative activity was determined by incorporation of [3H]-thymidine into hepatic DNA as well as by measurement of liver remnant weight. Following partial hepatectomy, there was a trend towards an increase in liver remnant weight at 24 h in rats treated with DES (DES, 5.95 +/- 1.52 g; vehicle, 4.87 +/- 0.66 g; P = 0.06) though by 48 h no effect was found. Tamoxifen treatment did not significantly affect liver weight at 24 h but by 48 h there was a highly significant reduction in liver remnant weight (TAM, 5.41 +/- 0.85 g; vehicle, 7.31 +/- 1.43 g; P < 0.001). Neither DES nor TAM treatment influenced liver regeneration as determined by [3H]-thymidine incorporation into hepatic DNA. We conclude that pharmacologic manipulation of oestrogens does not influence the initiation of the regenerative process but that oestrogen may facilitate later phases of hepatic growth.

摘要

雄性大鼠部分肝切除术后,血清雌激素水平升高,雌激素受体(ER)的核结合增加,肝脏代谢的某些方面出现雌性化。有人提出,这些变化可能在肝脏再生中起重要作用。本研究旨在确定雌激素激动剂己烯雌酚(DES)(2毫克/千克)和雌激素拮抗剂他莫昔芬(TAM)(2毫克/千克)对雄性大鼠部分肝切除诱导的肝脏再生的影响。通过将[3H] - 胸腺嘧啶掺入肝DNA以及测量肝残余重量来确定再生活性。部分肝切除术后,用DES治疗的大鼠在24小时时肝残余重量有增加的趋势(DES,5.95±1.52克;载体,4.87±0.66克;P = 0.06),但在48小时时未发现影响。他莫昔芬治疗在24小时时对肝脏重量没有显著影响,但在48小时时肝残余重量有极显著降低(TAM,5.41±0.85克;载体,7.31±1.43克;P <0.001)。通过将[3H] - 胸腺嘧啶掺入肝DNA来确定,DES和TAM治疗均未影响肝脏再生。我们得出结论,雌激素的药理操作不影响再生过程的启动,但雌激素可能促进肝脏生长的后期阶段。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验